BMSN. Nice. POST. Excerpt from pharma and biotech review , zachs research. Know what you hold here. Another quote from a very viable and noteworthy source. Huge potential with exactly the right business plan. See you on the up side real soon and be calm and patient. It will come to fruition.

Quote..."There has also been a significant pickup in in-licensing activities and collaborations for the development of pipeline candidates. Instead of developing a product from scratch, which involves a lot of funds, pharma companies are going shopping for mid-to late-stage pipeline candidates which look promising. As such, we would recommend investors to put their money in biotech stocks that have attractive pipeline candidates or technology that can be used for the development of novel therapeutics. Therapeutic areas which could see a lot of in-licensing activity include oncology, central nervous system disorders, diabetes and immunology/inflammation."
BMSN.